Market Overview

UPDATE: Piper Jaffray Downgrades Celanese Corporation to Neutral on Valuation, Outlook

Related CE
Celanese Introduces Medical Grades Of Tribological Polymer
Earnings Scheduled For October 20, 2014

Piper Jaffray downgraded Celanese Corporation (NYSE: CE) from Overweight to Neutral and maintained a $47.00 price target.

Piper Jaffray noted, "We are downgrading shares of CE to Neutral (from Overweight) as we believe that potential FY13 upside is largely baked into estimates (with consensus at +17% y/ y EPS growth) & valuation is fair (multiple already reflecting emerging mid-cycle performance). In addition, having no established market channels for industrial ethanol despite being 4-5 months from startup could pressure the profitability of ethanol production, and AEM will likely face increasingly difficult headwinds as sentiment sours on EU auto builds."

Celanese Corporation closed at $46.64 on Friday.

Latest Ratings for CE

DateFirmActionFromTo
Dec 2014NomuraInitiates Coverage onNeutral
Oct 2014CitigroupMaintainsNeutral
Jul 2014JP MorganMaintainsNeutral

View More Analyst Ratings for CE
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (CE)

Around the Web, We're Loving...

Get Benzinga's Newsletters